1h ago
Arcellx (ACLX) Jumps After Gilead's $7.8 Billion Acquisition Deal at $115 Per Share
On February 23, 2026, shares of Arcellx surged after Gilead Sciences agreed to buy the biotech company in a transaction valuing it at about $7.8 billion, including a $115 per share cash offer. The deal adds a potential $5 per share contingent value right tied to sales of Arcellx's CAR-T therapy anito-cel, while the stock price spiked to around $113.95 on heavy trading volume. The acquisition, expected to close in the second quarter of 2026, follows an existing partnership and could become accretive to Gilead's earnings after potential FDA approval.
ALCX
ALCX-2.09%
1h ago
4h ago
Vanda (VNDA) Soars 41.84% Premarket on FDA Approval of BYSANTI for Bipolar I and Schizophrenia
On February 23, 2026, Vanda Pharmaceuticals shares surged to $8.17 in premarket trading, up 41.84% from the prior close after the FDA cleared its new drug BYSANTI for adult Bipolar I manic episodes and schizophrenia. The approval, Vanda's second since December 2025, extends patent protection to 2044 and supports plans for a commercial launch in Q3 2026, boosting sentiment around the company's growth prospects.
4h ago
2-18
Global Payments, Insulet, and SolarEdge Post Q4 2025 Results and Issue 2026 Guidance
Global Payments, Insulet, and SolarEdge released their fourth-quarter 2025 figures, highlighting differing trends in revenue, earnings, and profitability. Global Payments and Insulet both topped revenue expectations, while SolarEdge reported a GAAP net loss despite strong year-over-year sales growth. All three companies set targets for 2026, outlining guidance on revenue expansion, margins, and earnings growth.
2-18
2-18
Western Digital to Unload $3.17B Sandisk Stake at Discount, SNDK Slides Ahead of February 18, 2026 Session
Sandisk Corporation's stock declined on February 18, 2026, after Western Digital moved to sell $3.17 billion worth of its shares in a discounted secondary offering. The deal, involving a debt-for-equity swap with J.P. Morgan and BofA Securities, comes at up to a 9.4% discount to the prior close and put further pressure on SNDK in premarket trading. Despite the short-term drop, Sandisk has delivered triple-digit returns over the past year amid a NAND flash shortage and strong earnings.
2-18